Combined modality therapy of cT2N0M0 esophageal cancer The University of Texas M. D. Anderson Cancer Center experience

• Published in: Cancer Vol. 117; no. 5; pp. 925 - 930
• Main Authors: Kountourakis, Panteleimon, Correa, Arlene M., Hofstetter, Wayne L., Lee, Jeffrey H., Bhutani, Manoop S., Rice, David C., Komaki, Ritsuko, Maru, Dipen M., Ross, William A., Vaporciyan, Ara, Swisher, Stephen G., Ajani, Jaffer A.
• Format: Journal Article
• Language: English
• Published: Hoboken, NJ Wiley-Blackwell 01.03.2011
• Subjects: Adenocarcinoma - mortality; Adenocarcinoma - pathology; Adenocarcinoma - therapy; Adult; Aged; Biological and medical sciences; Combined Modality Therapy; Esophageal Neoplasms - mortality; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Esophagus; Female; Follow-Up Studies; Gastroenterology. Liver. Pancreas. Abdomen; Hospitals, University; Humans; Male; Medical sciences; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Tumors; United States; North America; Texas; America; cT2N0M0; Cancerology; esophageal cancer; University; Esophageal disease; Digestive diseases; Combined treatment; prognostic factors; Malignant tumor; preoperative chemoradiotherapy; Esophagus cancer; Cancer

Treatment strategy for patients with adequately staged cT2N0M0 carcinoma of the thoracic esophagus is currently a subject of debate. This study analyzed the largest series of consecutive cT2N0M0 esophageal cancer patients treated with preoperative chemoradiotherapy. Data from all patients with cT2N0...